Topic

Comprehensive Genomic Profiling (CGP)

  • Uncovering Insights in Pancreatic and Prostate Cancers

    Most know a pancreatic cancer diagnosis is devastating. We’ve seen Patrick Swayze, Michael Landon, and Steve Jobs taken too soon by this terrible disease. We know survival is rare. Only 9 percent of patients live five years after diagnosis.1 Many may not realize, however, that prostate cancer can also be devastating, …

    Continue Reading

  • Recognizing Value Through Collaboration

    As adoption of comprehensive genomic profiling (CGP) becomes more widespread in cancer treatment, new research is redefining the clinical utility of diagnostic tests in this age of precision medicine. The value of CGP lies in helping to inform decisions on available treatment options, including clinical trial …

    Continue Reading

  • The oncology community is gearing up for the largest gathering of the year, the American Society of Clinical Oncology Annual Meeting (ASCO), which will take place June 3-7 in Chicago. The meeting is a critically important annual gathering of thousands of experts where the latest scientific breakthroughs and exciting …

    Continue Reading

  • A new study published in the April 16 edition of The Oncologist reveals that the majority of gastric cancers harbor at least one clinically relevant genomic alteration, demonstrating the utility of comprehensive genomic profiling to match patients to targeted therapy options and relevant clinical trials. Gastric …

    Continue Reading